This paper is in the following e-collection/theme issue:

Web-based and Mobile Health Interventions (3345)

Published on in Vol 21, No 1 (2019): January

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/11250, first published .
Web-Based Exercise as an Effective Complementary Treatment for Patients With Nonalcoholic Fatty Liver Disease: Intervention Study

Web-Based Exercise as an Effective Complementary Treatment for Patients With Nonalcoholic Fatty Liver Disease: Intervention Study

Web-Based Exercise as an Effective Complementary Treatment for Patients With Nonalcoholic Fatty Liver Disease: Intervention Study

Authors of this article:

Daniel Pfirrmann1 Author Orcid Image ;   Yvonne Huber2 Author Orcid Image ;   Jörn Markus Schattenberg2 Author Orcid Image ;   Perikles Simon1 Author Orcid Image
Article Authors Cited by (22) Tweetations (7) Metrics

Journals

  1. Grønkjær L, Wernberg C, Lauridsen M. Non-alcoholic fatty liver disease: the role of the nurse. Gastrointestinal Nursing 2020;18(Sup6):S15 View
  2. O’Gorman P, Naimimohasses S, Monaghan A, Kennedy M, Melo A, Ní Fhloinn D, Doherty D, Beddy P, Finn S, Moore J, Gormley J, Norris S. Improvement in histological endpoints of MAFLD following a 12‐week aerobic exercise intervention. Alimentary Pharmacology & Therapeutics 2020;52(8):1387 View
  3. Huber Y, Pfirrmann D, Gebhardt I, Labenz C, Gehrke N, Straub B, Ruckes C, Bantel H, Belda E, Clément K, Leeming D, Karsdal M, Galle P, Simon P, Schattenberg J. Improvement of non‐invasive markers of NAFLD from an individualised, web‐based exercise program. Alimentary Pharmacology & Therapeutics 2019;50(8):930 View
  4. O’Gorman P, Monaghan A, McGrath M, Naimimohasses S, Gormley J, Norris S. Determinants of Physical Activity Engagement in Patients With Nonalcoholic Fatty Liver Disease: The Need for an Individualized Approach to Lifestyle Interventions. Physical Therapy 2021;101(2) View
  5. O'Gorman P, Norris S. Exercising in the COVID-19 era: implications in non-alcoholic fatty liver disease (NAFLD). BMJ Open Gastroenterology 2021;8(1):e000568 View
  6. Motz V, Faust A, Dahmus J, Stern B, Soriano C, Stine J. Utilization of a Directly Supervised Telehealth-Based Exercise Training Program in Patients With Nonalcoholic Steatohepatitis: Feasibility Study. JMIR Formative Research 2021;5(8):e30239 View
  7. Su S, Huang C, Gung R, Hsiung L, Gao Z, Tsai C. A Decision Support System with Artificial Intelligence and Natural Language Processing to Mitigate the Deduction Rate of Health Insurance Claims. Applied Sciences 2021;11(24):11623 View
  8. Haller N. Web-based exercise therapy for the treatment of depression. Sports Psychiatry 2022;1(3):119 View
  9. Kwon O, Choi J, Jang Y. The Effectiveness of eHealth Interventions on Lifestyle Modification in Patients With Nonalcoholic Fatty Liver Disease: Systematic Review and Meta-analysis. Journal of Medical Internet Research 2023;25:e37487 View
  10. Ochmann D, Philippi K, Zeier P, Sandner M, Hillen B, Neuberger E, Ruiz de Azua I, Lieb K, Wessa M, Lutz B, Simon P, Brahmer A. Association of Innate and Acquired Aerobic Capacity With Resilience in Healthy Adults: Protocol for a Randomized Controlled Trial of an 8-Week Web-Based Physical Exercise Intervention. JMIR Research Protocols 2021;10(11):e29712 View
  11. Zhou R, Gu Y, Zhang B, Kong T, Zhang W, Li J, Shi J. Digital Therapeutics: Emerging New Therapy for Nonalcoholic Fatty Liver Disease. Clinical and Translational Gastroenterology 2023;14(4):e00575 View
  12. Balakrishnan M, Liu K, Schmitt S, Heredia N, Sisson A, Montealegre J, Hernaez R, Kanwal F, Foreyt J. Behavioral weight-loss interventions for patients with NAFLD: A systematic scoping review. Hepatology Communications 2023;7(8) View
  13. Younossi Z, Zelber-Sagi S, Henry L, Gerber L. Lifestyle interventions in nonalcoholic fatty liver disease. Nature Reviews Gastroenterology & Hepatology 2023;20(11):708 View
  14. Seifi N, Bahari H, Soltani S, Nikoumanesh M, Hajipoor M, Ferns G, Ghayour-Mobarhan M. The effects of electronic-based lifestyle interventions on nonalcoholic fatty liver disease: A systematic review. DIGITAL HEALTH 2023;9 View
  15. Kwon O, Lee M, Lee H, Kim H, Lee J, Jang Y. Mobile App–Based Lifestyle Coaching Intervention for Patients With Nonalcoholic Fatty Liver Disease: Randomized Controlled Trial. Journal of Medical Internet Research 2024;26:e49839 View
  16. Freer C, George E, Tan S, Abbott G, Daly R. Delivery of a telehealth supported home exercise program with dietary advice to increase plant-based protein intake in people with non-alcoholic fatty liver disease: a 12-week randomised controlled feasibility trial. British Journal of Nutrition 2024:1 View
  17. Younossi Z, Henry L. Understanding the Burden of Nonalcoholic Fatty Liver Disease: Time for Action. Diabetes Spectrum 2024;37(1):9 View
  18. Philippi K, Zeier P, Brahmer A, Neuberger E, Sandner M, Hagenah M, Porten T, Lenz R, Ochmann D, Wedekink F, Wischhusen J, Lutz B, Lieb K, Wessa M, Simon P. Remote Exercise Training Intervention During the COVID-19 Pandemic: Randomized Controlled Trial. Journal of Medical Internet Research 2024;26:e53145 View
  19. Albhaisi S, Tondt J, Cyrus J, Chinchilli V, Conroy D, Stine J. Digital therapeutics lead to clinically significant body weight loss in patients with metabolic dysfunction–associated steatotic liver disease: A systematic review and meta-analysis. Hepatology Communications 2024;8(8) View
  20. Namjou Z, Jafari S, Rezaeian A, Ghayour-Mobarhan M, Nasrfard S. The effect of nutritional education program on micronutrient intake in children with chronic liver disease. Journal of Education and Health Promotion 2021;10(1):416 View
  21. Rowland S, Bach C, Simon K, Westmark D, Sperling E. Effectiveness of digital health interventions to increase cardiorespiratory fitness: A systematic review and meta-analysis. DIGITAL HEALTH 2024;10 View
  22. Ivancovsky Wajcman D, Byrne C, Dillon J, Brennan P, Villota-Rivas M, Younossi Z, Allen A, Crespo J, Gerber L, Lazarus J. A narrative review of lifestyle management guidelines for metabolic dysfunction–associated steatotic liver disease. Hepatology 2024 View